Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Product/Service, Sales, Business Update

PQE Group: 100+M? in Revenues


PQE Group, the renowned Life Science consulting powerhouse, concludes the fiscal year 2023 with a 10% growth and an upwardly revised income exceeding 100 million euros in revenues. The Italian headquartered global firm, celebrated as a preferred advisor to pharma manufacturing and medical device corporations and SMEs globally, marks this success as a testament to its resilience, adaptability, and strategic vision amid the complex global landscape.

"At a time when many companies grapple with geopolitical challenges, crises, and inflation rates, PQE Group stands out not only for its resilience but for its ability to thrive in uncertain times, showcasing positive growth across all financial indicators," stated Gilda D'Incerti, PQE Group CEO & Founder. "This success is rooted in meticulous planning, strategic investments in cutting-edge technologies, and a corporate culture that values agility and innovation."
The recently concluded year for PQE Group is characterized by a distinctive focus on process optimization and digital investments. Having concluded 2022 with a remarkable 68% increase in revenues compared to the previous year, the company executed a robust reorganizational strategy in 2023, positioning PQE Group at its most efficient. A driving force behind the enhanced net revenue margin is the company's commitment to process efficiency, serving as a catalyst for a significant phase of innovation.

This is exemplified by the establishment of ReSQ-Up, the group's internal Contract Research Organization (CRO), dedicated to supporting companies in collaboration with hospitals, start-ups, and research institutes in their clinical trials for innovative products. ReSQ-Up introduces a new paradigm in clinical research, with a specific focus on women's health and the application of therapeutic cannabis. In parallel, PQE Group has expanded its global footprint with the inauguration of new offices in Canada, Saudi Arabia, Ireland and Singapore, bringing the total to 46 offices worldwide and 26 legal entities. This strategic expansion aims to connect PQE Group with burgeoning markets, particularly in Southeast Asia.

Stefano Carganico, PQE Group Chief Innovation Officer, emphasized the company's commitment to sustainability, stating: "We strategically invested in digital solutions and eco-friendly; this not only enhances our efficiency, but also contributes to environmental protection. After years of hyper growth and consolidation, we have set our sights on more ambitious and long-term goals, incorporating sustainability into our strategic process."


These press releases may also interest you

at 08:39
SG360°, a leading provider of integrated print and addressable marketing solutions, proudly announces it has achieved the highly esteemed HITRUST r2 certification. Recognized globally as the gold standard for data security, the HITRUST r2...

at 08:37
Wild West Children's Dentistry, a local family dentist in Arizona, is proud to announce its expansion to an impressive nine locations across the state. With offices now in Gilbert, Scottsdale, Glendale, Biltmore, Central Phoenix, Mesa, Phoenix, ...

at 08:37
Palliative care is a key aspect of recovery for many patients. Unlike hospice care (which is designed to maintain comfort and quality of life for a terminally ill patient), palliative care seeks to ease discomfort during a lengthy medical procedure,...

at 08:37
Proactive Healthcare Staffing, a leading medical staffing agency in Washington State, has distinguished themselves by employing 100% of its clinicians as W-2 employees rather than 1099 contractors. This strategic choice ensures enhanced quality care...

at 08:35
Silence Therapeutics plc ("Silence" or the "Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing diseases through precision engineered medicines, today announced that Alistair Gray, who...

at 08:35
CLEW, a clinical intelligence and predictive surveillance company, today announced the general availability of its FDA-cleared, AI-driven, intelligent clinical surveillance platform. Built upon proprietary, machine-learning derived prediction models...



News published on and distributed by: